Abraham N G, da Silva J L, Lavrovsky Y, Stoltz R A, Kappas A, Dunn M W, Schwartzman M L
Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2202-10.
Heme oxygenase-1 (HO-1) is a stress protein induced up to 100-fold within a few hours after exposure to oxidative stress, and it has been shown to counteract oxidative injury induced by ultraviolet light or free radicals. The current study was undertaken to determine whether the HO-1 gene can be introduced into adult rabbit ocular tissues by microinjection of a recombinant replication-deficient adenovirus human HO-1 cDNA (Adv-HHO).
Human HO-1 gene was used for transfection studies to differentiate endogenous from transfected HO. The purified Adv-HHO construct (10(8) pfu/ml) was mixed with lipofectamine and microinjected into the anterior chamber, vitreous cavity, and subretinal space of New Zealand rabbit eyes. After 2 weeks, total RNA was extracted from different ocular tissues, reverse transcription-polymerase chain reaction was performed using specific human HO-1 primers, and amplification products were subjected to Southern hybridization.
Transfection with the Adv-HHO construct into rabbit corneal epithelial cells in culture resulted in a functional expression of the human HO-1 gene; the human HO-1 mRNA was detected, and enzyme activity increased threefold. Human HO-1 mRNA was detected in the retina after microinjection of the Adv-HHO construct into the subretinal space. Microinjection into the vitreous resulted in HO-1 mRNA expression in the corneal endothelium, iris, lens, and retina; after intracameral injection of the Adv-HHO construct, human HO-1 mRNA was detected in corneal epithelium and endothelium, ciliary body, lens, and iris. Regardless of the injection site, transfected human HO-1 mRNA was undetectable in tissues outside the eye, that is, brain, liver, and kidney.
These results demonstrated a tissue-selective functional transfer of the human HO-1 gene into rabbit ocular tissues in vivo. This technique may be a promising means for delivering HO-1 gene in vivo as a protective mechanism against oxidative stress that contributes to the pathogenesis of ocular diseases such as cataract, light-induced injury, age-related macular degeneration, and diabetic retinopathy.
血红素加氧酶-1(HO-1)是一种应激蛋白,在暴露于氧化应激后数小时内可诱导其表达增加至100倍,并且已证明它可对抗紫外线或自由基诱导的氧化损伤。当前研究旨在确定通过显微注射重组复制缺陷型腺病毒人HO-1 cDNA(Adv-HHO)是否能将HO-1基因导入成年兔眼组织。
使用人HO-1基因进行转染研究,以区分内源性HO和转染的HO。将纯化的Adv-HHO构建体(10⁸ pfu/ml)与脂质体转染试剂混合,并显微注射到新西兰兔眼的前房、玻璃体腔和视网膜下间隙。2周后,从不同眼组织中提取总RNA,使用特异性人HO-1引物进行逆转录-聚合酶链反应,并对扩增产物进行Southern杂交。
将Adv-HHO构建体转染至培养的兔角膜上皮细胞可导致人HO-1基因的功能性表达;检测到了人HO-1 mRNA,且酶活性增加了三倍。将Adv-HHO构建体显微注射到视网膜下间隙后,在视网膜中检测到了人HO-1 mRNA。显微注射到玻璃体中导致角膜内皮、虹膜、晶状体和视网膜中HO-1 mRNA表达;在房内注射Adv-HHO构建体后,在角膜上皮和内皮、睫状体、晶状体和虹膜中检测到了人HO-1 mRNA。无论注射部位如何,在眼外组织(即脑、肝和肾)中均未检测到转染的人HO-1 mRNA。
这些结果证明了人HO-1基因在体内向兔眼组织的组织选择性功能转移。该技术可能是一种有前景的体内递送HO-1基因的手段,作为一种针对氧化应激的保护机制,氧化应激在诸如白内障、光诱导损伤、年龄相关性黄斑变性和糖尿病性视网膜病变等眼部疾病的发病机制中起作用。